サンプル依頼リスト カート
  • English
  • Korean
デフォルト表紙
市場調査レポート
商品コード
1788380

トリプシンの世界市場

Trypsin

出版日
ページ情報
英文 178 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=148.55円
トリプシンの世界市場
出版日: 2025年08月12日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 178 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

トリプシンの世界市場は2030年までに1億4,280万米ドルに達する見込み

2024年に1億390万米ドルと推定されるトリプシンの世界市場は、2024年から2030年にかけてCAGR 5.5%で成長し、2030年には1億4,280万米ドルに達すると予測されます。本レポートで分析されているセグメントの一つである牛は、CAGR 5.2%を記録し、分析期間終了時には9,200万米ドルに達すると予想されています。豚肉セグメントの成長率は、分析期間でCAGR 6.4％と推定されます。

米国市場は2,730万米ドルと推定、中国はCAGR 5.3％で成長すると予測

米国のトリプシン市場は、2024年には2,730万米ドルと推定されます。世界第2位の経済大国である中国は、2030年までに2,290万米ドルの市場規模に達すると予測され、分析期間2024-2030年のCAGRは5.3%です。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ4.8％と4.8％と予測されています。欧州では、ドイツがCAGR 4.4%で成長すると予測されています。

トリプシン市場の動向と促進要因のまとめ

トリプシンはバイオ医薬品と食品加工の主要酵素としてどのように進化しているか？

トリプシンは、バイオテクノロジー、医薬品、食品加工で広く使用されているタンパク質分解酵素であり、その多様な用途により市場で脚光を浴びています。バイオ医薬品では、トリプシンは細胞培養、タンパク質消化、プロテオミクス研究におけるペプチドマッピングに不可欠です。食品加工では、タンパク質の加水分解に使用され、食品の食感や消化性を向上させます。さらに、トリプシンは創傷治癒のための製剤や診断キットに不可欠であり、医療用途を拡大しています。しかし、酵素の安定性、高い生産コスト、バイオ医薬品用途における規制遵守などの課題は依然としてハードルとなっています。酵素工学の進歩に伴い、次世代のトリプシン製剤はどのように効率を高め、産業用途を拡大していくのだろうか。

トリプシン生産を進める技術革新とは？

組換え酵素生産と生物工学の開発により、トリプシンの安定性と活性が向上しています。AIによる酵素の最適化により、特異性が向上し、分解率が低下しています。固定化トリプシン技術により再利用性が向上し、医薬品や食品用途での生産コストが削減されています。さらに、精密な発酵法により、動物由来の原料への依存を減らし、大規模で持続可能なトリプシン生産が可能になっています。

なぜトリプシンの需要が増加しているのか？

バイオ医薬品産業の拡大、プロテオミクス研究ツールに対する需要の高まり、酵素食品加工技術の採用増加などがトリプシン市場の成長を後押ししています。植物ベースのタンパク質加水分解と代替食肉加工への嗜好の高まりが、食品技術における酵素応用をさらに促進しています。さらに、再生医療と酵素ベースの治療薬の進歩は、創傷治療と医薬品開発におけるトリプシンの新たな機会を開いています。

トリプシン市場の成長を促進する要因は？

バイオ医薬品製造への投資の増加、酵素工学の進歩、持続可能な食品加工ソリューションへの需要の高まり、医療診断への応用の拡大により、市場は拡大しています。酵素技術が進化し続ける中、トリプシンはバイオテクノロジー、ヘルスケア、食品イノベーションにおいてますます重要な役割を果たすことが期待されています。

セグメント

供給源（牛、豚、その他）、用途（製薬・バイオテクノロジー企業、食品、化粧品・パーソナルケア、廃棄物治療、その他）、最終用途（調査、診断、産業用）

調査対象企業の例

  • Abbexa Ltd
  • Abcam
  • Ann Organic India Private Limited
  • Apollo Ingredients Pvt Ltd
  • Athens Research & Technology
  • BBI Solutions
  • Beloorbayir Biotech
  • BioZym
  • Codexis, Inc.
  • Creative Enzymes
  • DakeGlobal Industry Analysts Biotech
  • Eli Lilly and Company
  • Enzyme Bioscience Pvt Ltd
  • Genovis AB
  • Hawkins, Inc.
  • Hzymes Biotech
  • Linzyme Biosciences
  • Merck KGaA
  • Novozymes A/S
  • Promega Corporation
  • Roche Holding AG
  • Sigma-Aldrich

AIインテグレーション

Global Industry Analystsは、有効な専門家コンテンツとAIツールによって、市場情報と競合情報を変革しています。

Global Industry Analystsは、LLMや業界固有のSLMを照会する一般的な規範に従う代わりに、ビデオ記録、ブログ、検索エンジン調査、膨大な量の企業、製品/サービス、市場データなど、世界中の専門家から収集したコンテンツのリポジトリを構築しました。

関税影響係数

Global Industry Analystsは、本社の国、製造拠点、輸出入（完成品とOEM）に基づく企業の競争力の変化を予測しています。この複雑で多面的な市場力学は、売上原価（COGS）の増加、収益性の低下、サプライチェーンの再構築など、ミクロおよびマクロの市場力学の中でも特に競合他社に影響を与える見込みです。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • その他欧州
  • アジア太平洋
  • その他の地域

第4章 競合

目次
Product Code: MCP33191

Global Trypsin Market to Reach US$142.8 Million by 2030

The global market for Trypsin estimated at US$103.9 Million in the year 2024, is expected to reach US$142.8 Million by 2030, growing at a CAGR of 5.5% over the analysis period 2024-2030. Bovine, one of the segments analyzed in the report, is expected to record a 5.2% CAGR and reach US$92.0 Million by the end of the analysis period. Growth in the Porcine segment is estimated at 6.4% CAGR over the analysis period.

The U.S. Market is Estimated at US$27.3 Million While China is Forecast to Grow at 5.3% CAGR

The Trypsin market in the U.S. is estimated at US$27.3 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$22.9 Million by the year 2030 trailing a CAGR of 5.3% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 4.8% and 4.8% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.4% CAGR.

Trypsin Market Trends & Drivers Summarized

How Is Trypsin Evolving as a Key Enzyme in Biopharmaceuticals and Food Processing?

Trypsin, a proteolytic enzyme widely used in biotechnology, pharmaceuticals, and food processing, is gaining market prominence due to its diverse applications. In biopharmaceuticals, trypsin is essential for cell culture, protein digestion, and peptide mapping in proteomics research. In food processing, it is used for protein hydrolysis, improving food texture and digestibility. Additionally, trypsin is integral in wound healing formulations and diagnostic kits, expanding its medical applications. However, challenges such as enzyme stability, high production costs, and regulatory compliance in biopharmaceutical applications remain hurdles. As enzyme engineering advances, how will next-generation trypsin formulations enhance efficiency and expand its industrial applications?

What Technological Innovations Are Advancing Trypsin Production?

Developments in recombinant enzyme production and bioengineering are improving trypsin stability and activity. AI-driven enzyme optimization is enhancing specificity and reducing degradation rates. Immobilized trypsin techniques are increasing reusability, lowering production costs in pharmaceutical and food applications. Additionally, precision fermentation methods are enabling large-scale, sustainable trypsin production with reduced reliance on animal-derived sources.

Why Is the Demand for Trypsin Increasing?

The expansion of the biopharmaceutical industry, rising demand for proteomics research tools, and increasing adoption of enzymatic food processing techniques are fueling trypsin market growth. The growing preference for plant-based protein hydrolysis and alternative meat processing is further driving enzyme applications in food technology. Additionally, advancements in regenerative medicine and enzyme-based therapeutics are opening new opportunities for trypsin in wound care and drug development.

What Factors Are Driving the Growth of the Trypsin Market?

The market is expanding due to increasing investment in biopharmaceutical manufacturing, advancements in enzyme engineering, rising demand for sustainable food processing solutions, and growing applications in medical diagnostics. As enzyme technology continues to evolve, trypsin is expected to play an increasingly important role in biotechnology, healthcare, and food innovation.

SCOPE OF STUDY:

The report analyzes the Trypsin market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Source (Bovine, Porcine, Others); Application (Pharma & Biotech Companies, Food, Cosmetics & Personal Care, Waste Treatment, Others); End-Use (Research, Diagnostics, Industrial)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 42 Featured) -

  • Abbexa Ltd
  • Abcam
  • Ann Organic India Private Limited
  • Apollo Ingredients Pvt Ltd
  • Athens Research & Technology
  • BBI Solutions
  • Beloorbayir Biotech
  • BioZym
  • Codexis, Inc.
  • Creative Enzymes
  • Dakewe Biotech
  • Eli Lilly and Company
  • Enzyme Bioscience Pvt Ltd
  • Genovis AB
  • Hawkins, Inc.
  • Hzymes Biotech
  • Linzyme Biosciences
  • Merck KGaA
  • Novozymes A/S
  • Promega Corporation
  • Roche Holding AG
  • Sigma-Aldrich

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Trypsin - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Expanding Applications in Biopharmaceuticals and Biotechnology Drives Industrial-Grade Trypsin Demand
    • Growth in Food and Beverage Industry Spurs Adoption in Protein Hydrolysis and Flavor Enhancement
    • Advancements in Enzyme Engineering Propel High-Stability Trypsin Formulations
    • Shift Toward Recombinant Trypsin Strengthens Safety and Regulatory Compliance
    • Rising Use in Diagnostic Assays Expands Biomedical Market Relevance
    • Application in Waste Treatment Processes Creates Demand in Environmental Solutions
    • Increasing Use in Cosmetic and Personal Care Products Enhances Market Penetration
    • Academic and Research Institute Adoption Broadens Consumables Demand
    • Development of Immobilized Trypsin Improves Reusability and Cost Efficiency
    • Regulatory Support for Enzyme-Based Industrial Processes Encourages Uptake
    • Projected Market Growth Reinforces Commercial Viability of Trypsin Across Sectors
    • Regional Expansion in North America and Asia-Pacific Fuels Global Supply Chain Activity
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Trypsin Market Analysis of Annual Sales in US$ for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Trypsin by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 3: World 6-Year Perspective for Trypsin by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2025 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Bovine by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 5: World 6-Year Perspective for Bovine by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 6: World Recent Past, Current & Future Analysis for Porcine by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 7: World 6-Year Perspective for Porcine by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Other Sources by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 9: World 6-Year Perspective for Other Sources by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 11: World 6-Year Perspective for Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 12: World Recent Past, Current & Future Analysis for Industrial by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 13: World 6-Year Perspective for Industrial by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Research by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 15: World 6-Year Perspective for Research by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Pharma & Biotech Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 17: World 6-Year Perspective for Pharma & Biotech Companies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 18: World Recent Past, Current & Future Analysis for Food by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 19: World 6-Year Perspective for Food by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Cosmetics & Personal Care by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 21: World 6-Year Perspective for Cosmetics & Personal Care by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 22: World Recent Past, Current & Future Analysis for Waste Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 23: World 6-Year Perspective for Waste Treatment by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 24: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 25: World 6-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Trypsin Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 26: USA Recent Past, Current & Future Analysis for Trypsin by Source - Bovine, Porcine and Other Sources - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 27: USA 6-Year Perspective for Trypsin by Source - Percentage Breakdown of Value Sales for Bovine, Porcine and Other Sources for the Years 2025 & 2030
    • TABLE 28: USA Recent Past, Current & Future Analysis for Trypsin by End-Use - Diagnostics, Industrial and Research - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 29: USA 6-Year Perspective for Trypsin by End-Use - Percentage Breakdown of Value Sales for Diagnostics, Industrial and Research for the Years 2025 & 2030
    • TABLE 30: USA Recent Past, Current & Future Analysis for Trypsin by Application - Pharma & Biotech Companies, Food, Cosmetics & Personal Care, Waste Treatment and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 31: USA 6-Year Perspective for Trypsin by Application - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Food, Cosmetics & Personal Care, Waste Treatment and Other Applications for the Years 2025 & 2030
  • CANADA
    • TABLE 32: Canada Recent Past, Current & Future Analysis for Trypsin by Source - Bovine, Porcine and Other Sources - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 33: Canada 6-Year Perspective for Trypsin by Source - Percentage Breakdown of Value Sales for Bovine, Porcine and Other Sources for the Years 2025 & 2030
    • TABLE 34: Canada Recent Past, Current & Future Analysis for Trypsin by End-Use - Diagnostics, Industrial and Research - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 35: Canada 6-Year Perspective for Trypsin by End-Use - Percentage Breakdown of Value Sales for Diagnostics, Industrial and Research for the Years 2025 & 2030
    • TABLE 36: Canada Recent Past, Current & Future Analysis for Trypsin by Application - Pharma & Biotech Companies, Food, Cosmetics & Personal Care, Waste Treatment and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 37: Canada 6-Year Perspective for Trypsin by Application - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Food, Cosmetics & Personal Care, Waste Treatment and Other Applications for the Years 2025 & 2030
  • JAPAN
    • Trypsin Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 38: Japan Recent Past, Current & Future Analysis for Trypsin by Source - Bovine, Porcine and Other Sources - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Japan 6-Year Perspective for Trypsin by Source - Percentage Breakdown of Value Sales for Bovine, Porcine and Other Sources for the Years 2025 & 2030
    • TABLE 40: Japan Recent Past, Current & Future Analysis for Trypsin by End-Use - Diagnostics, Industrial and Research - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 41: Japan 6-Year Perspective for Trypsin by End-Use - Percentage Breakdown of Value Sales for Diagnostics, Industrial and Research for the Years 2025 & 2030
    • TABLE 42: Japan Recent Past, Current & Future Analysis for Trypsin by Application - Pharma & Biotech Companies, Food, Cosmetics & Personal Care, Waste Treatment and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 43: Japan 6-Year Perspective for Trypsin by Application - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Food, Cosmetics & Personal Care, Waste Treatment and Other Applications for the Years 2025 & 2030
  • CHINA
    • Trypsin Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 44: China Recent Past, Current & Future Analysis for Trypsin by Source - Bovine, Porcine and Other Sources - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 45: China 6-Year Perspective for Trypsin by Source - Percentage Breakdown of Value Sales for Bovine, Porcine and Other Sources for the Years 2025 & 2030
    • TABLE 46: China Recent Past, Current & Future Analysis for Trypsin by End-Use - Diagnostics, Industrial and Research - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 47: China 6-Year Perspective for Trypsin by End-Use - Percentage Breakdown of Value Sales for Diagnostics, Industrial and Research for the Years 2025 & 2030
    • TABLE 48: China Recent Past, Current & Future Analysis for Trypsin by Application - Pharma & Biotech Companies, Food, Cosmetics & Personal Care, Waste Treatment and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 49: China 6-Year Perspective for Trypsin by Application - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Food, Cosmetics & Personal Care, Waste Treatment and Other Applications for the Years 2025 & 2030
  • EUROPE
    • Trypsin Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Trypsin by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 51: Europe 6-Year Perspective for Trypsin by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2025 & 2030
    • TABLE 52: Europe Recent Past, Current & Future Analysis for Trypsin by Source - Bovine, Porcine and Other Sources - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 53: Europe 6-Year Perspective for Trypsin by Source - Percentage Breakdown of Value Sales for Bovine, Porcine and Other Sources for the Years 2025 & 2030
    • TABLE 54: Europe Recent Past, Current & Future Analysis for Trypsin by End-Use - Diagnostics, Industrial and Research - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 55: Europe 6-Year Perspective for Trypsin by End-Use - Percentage Breakdown of Value Sales for Diagnostics, Industrial and Research for the Years 2025 & 2030
    • TABLE 56: Europe Recent Past, Current & Future Analysis for Trypsin by Application - Pharma & Biotech Companies, Food, Cosmetics & Personal Care, Waste Treatment and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Europe 6-Year Perspective for Trypsin by Application - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Food, Cosmetics & Personal Care, Waste Treatment and Other Applications for the Years 2025 & 2030
  • FRANCE
    • Trypsin Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 58: France Recent Past, Current & Future Analysis for Trypsin by Source - Bovine, Porcine and Other Sources - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 59: France 6-Year Perspective for Trypsin by Source - Percentage Breakdown of Value Sales for Bovine, Porcine and Other Sources for the Years 2025 & 2030
    • TABLE 60: France Recent Past, Current & Future Analysis for Trypsin by End-Use - Diagnostics, Industrial and Research - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 61: France 6-Year Perspective for Trypsin by End-Use - Percentage Breakdown of Value Sales for Diagnostics, Industrial and Research for the Years 2025 & 2030
    • TABLE 62: France Recent Past, Current & Future Analysis for Trypsin by Application - Pharma & Biotech Companies, Food, Cosmetics & Personal Care, Waste Treatment and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 63: France 6-Year Perspective for Trypsin by Application - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Food, Cosmetics & Personal Care, Waste Treatment and Other Applications for the Years 2025 & 2030
  • GERMANY
    • Trypsin Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 64: Germany Recent Past, Current & Future Analysis for Trypsin by Source - Bovine, Porcine and Other Sources - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 65: Germany 6-Year Perspective for Trypsin by Source - Percentage Breakdown of Value Sales for Bovine, Porcine and Other Sources for the Years 2025 & 2030
    • TABLE 66: Germany Recent Past, Current & Future Analysis for Trypsin by End-Use - Diagnostics, Industrial and Research - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 67: Germany 6-Year Perspective for Trypsin by End-Use - Percentage Breakdown of Value Sales for Diagnostics, Industrial and Research for the Years 2025 & 2030
    • TABLE 68: Germany Recent Past, Current & Future Analysis for Trypsin by Application - Pharma & Biotech Companies, Food, Cosmetics & Personal Care, Waste Treatment and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Germany 6-Year Perspective for Trypsin by Application - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Food, Cosmetics & Personal Care, Waste Treatment and Other Applications for the Years 2025 & 2030
  • ITALY
    • TABLE 70: Italy Recent Past, Current & Future Analysis for Trypsin by Source - Bovine, Porcine and Other Sources - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 71: Italy 6-Year Perspective for Trypsin by Source - Percentage Breakdown of Value Sales for Bovine, Porcine and Other Sources for the Years 2025 & 2030
    • TABLE 72: Italy Recent Past, Current & Future Analysis for Trypsin by End-Use - Diagnostics, Industrial and Research - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 73: Italy 6-Year Perspective for Trypsin by End-Use - Percentage Breakdown of Value Sales for Diagnostics, Industrial and Research for the Years 2025 & 2030
    • TABLE 74: Italy Recent Past, Current & Future Analysis for Trypsin by Application - Pharma & Biotech Companies, Food, Cosmetics & Personal Care, Waste Treatment and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Italy 6-Year Perspective for Trypsin by Application - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Food, Cosmetics & Personal Care, Waste Treatment and Other Applications for the Years 2025 & 2030
  • UNITED KINGDOM
    • Trypsin Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 76: UK Recent Past, Current & Future Analysis for Trypsin by Source - Bovine, Porcine and Other Sources - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 77: UK 6-Year Perspective for Trypsin by Source - Percentage Breakdown of Value Sales for Bovine, Porcine and Other Sources for the Years 2025 & 2030
    • TABLE 78: UK Recent Past, Current & Future Analysis for Trypsin by End-Use - Diagnostics, Industrial and Research - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 79: UK 6-Year Perspective for Trypsin by End-Use - Percentage Breakdown of Value Sales for Diagnostics, Industrial and Research for the Years 2025 & 2030
    • TABLE 80: UK Recent Past, Current & Future Analysis for Trypsin by Application - Pharma & Biotech Companies, Food, Cosmetics & Personal Care, Waste Treatment and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 81: UK 6-Year Perspective for Trypsin by Application - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Food, Cosmetics & Personal Care, Waste Treatment and Other Applications for the Years 2025 & 2030
  • REST OF EUROPE
    • TABLE 82: Rest of Europe Recent Past, Current & Future Analysis for Trypsin by Source - Bovine, Porcine and Other Sources - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 83: Rest of Europe 6-Year Perspective for Trypsin by Source - Percentage Breakdown of Value Sales for Bovine, Porcine and Other Sources for the Years 2025 & 2030
    • TABLE 84: Rest of Europe Recent Past, Current & Future Analysis for Trypsin by End-Use - Diagnostics, Industrial and Research - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 85: Rest of Europe 6-Year Perspective for Trypsin by End-Use - Percentage Breakdown of Value Sales for Diagnostics, Industrial and Research for the Years 2025 & 2030
    • TABLE 86: Rest of Europe Recent Past, Current & Future Analysis for Trypsin by Application - Pharma & Biotech Companies, Food, Cosmetics & Personal Care, Waste Treatment and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Rest of Europe 6-Year Perspective for Trypsin by Application - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Food, Cosmetics & Personal Care, Waste Treatment and Other Applications for the Years 2025 & 2030
  • ASIA-PACIFIC
    • Trypsin Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 88: Asia-Pacific Recent Past, Current & Future Analysis for Trypsin by Source - Bovine, Porcine and Other Sources - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 89: Asia-Pacific 6-Year Perspective for Trypsin by Source - Percentage Breakdown of Value Sales for Bovine, Porcine and Other Sources for the Years 2025 & 2030
    • TABLE 90: Asia-Pacific Recent Past, Current & Future Analysis for Trypsin by End-Use - Diagnostics, Industrial and Research - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 91: Asia-Pacific 6-Year Perspective for Trypsin by End-Use - Percentage Breakdown of Value Sales for Diagnostics, Industrial and Research for the Years 2025 & 2030
    • TABLE 92: Asia-Pacific Recent Past, Current & Future Analysis for Trypsin by Application - Pharma & Biotech Companies, Food, Cosmetics & Personal Care, Waste Treatment and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Asia-Pacific 6-Year Perspective for Trypsin by Application - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Food, Cosmetics & Personal Care, Waste Treatment and Other Applications for the Years 2025 & 2030
  • REST OF WORLD
    • TABLE 94: Rest of World Recent Past, Current & Future Analysis for Trypsin by Source - Bovine, Porcine and Other Sources - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 95: Rest of World 6-Year Perspective for Trypsin by Source - Percentage Breakdown of Value Sales for Bovine, Porcine and Other Sources for the Years 2025 & 2030
    • TABLE 96: Rest of World Recent Past, Current & Future Analysis for Trypsin by End-Use - Diagnostics, Industrial and Research - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 97: Rest of World 6-Year Perspective for Trypsin by End-Use - Percentage Breakdown of Value Sales for Diagnostics, Industrial and Research for the Years 2025 & 2030
    • TABLE 98: Rest of World Recent Past, Current & Future Analysis for Trypsin by Application - Pharma & Biotech Companies, Food, Cosmetics & Personal Care, Waste Treatment and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Rest of World 6-Year Perspective for Trypsin by Application - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Food, Cosmetics & Personal Care, Waste Treatment and Other Applications for the Years 2025 & 2030

IV. COMPETITION